Nerve growth factor for neuropathic pain

Yang Zhang, Siyin Gong, Li He, Muke Zhou, Jian Guo, Ahmet Hoke, Cairong Zhu

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the analgesic efficacy and adverse effects of nerve growth factor for chronic neuropathic pain.

Original languageEnglish (US)
Article numberCD012800
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number11
DOIs
StatePublished - Nov 4 2017

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Nerve growth factor for neuropathic pain'. Together they form a unique fingerprint.

  • Cite this

    Zhang, Y., Gong, S., He, L., Zhou, M., Guo, J., Hoke, A., & Zhu, C. (2017). Nerve growth factor for neuropathic pain. Cochrane Database of Systematic Reviews, 2017(11), [CD012800]. https://doi.org/10.1002/14651858.CD012800